Characterization of Mycobacterium orygis, Mycobacterium bovis, and Mycobacterium caprae Infections in Humans in Western Canada.

Animal Diseases Bovine Cattle Diseases Extrapulmonary Mycobacterium Infections Mycobacterium bovis Mycobacterium orygis Mycobacterium tuberculosis Tuberculosis Zoonoses

Journal

The Journal of infectious diseases
ISSN: 1537-6613
Titre abrégé: J Infect Dis
Pays: United States
ID NLM: 0413675

Informations de publication

Date de publication:
08 Mar 2024
Historique:
received: 06 12 2023
revised: 01 03 2024
accepted: 06 03 2024
medline: 8 3 2024
pubmed: 8 3 2024
entrez: 8 3 2024
Statut: aheadofprint

Résumé

Epidemiologic research on zoonotic tuberculosis historically used Mycobacterium bovis as a surrogate measure, however, increased reports of human tuberculosis caused by other animal-associated Mycobacterium tuberculosis complex members like Mycobacterium orygis necessitates their inclusion. We performed a retrospective cohort study including persons infected with any animal-lineage M. tuberculosis complex species in Alberta, Canada, from January 1995 to July 2021, identifying 42 patients (20 M. bovis, 21 M. orygis, one M. caprae). Demographic, epidemiologic and clinical characteristics were compared against persons with culture-confirmed M. tuberculosis infection. The proportion of culture-positive infections caused by M. orygis increased continuously from 2016-2020. Significantly more females at a higher median age were impacted by M. orygis, with all patients originating from South Asia. M. bovis caused significantly more extra-pulmonary disease, and disproportionately impacted young females, particularly those pregnant or post-partum. All infections were acquired abroad. These findings can aid in developing targeted public health interventions.

Identifiants

pubmed: 38456644
pii: 7624355
doi: 10.1093/infdis/jiae124
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America.

Auteurs

Nicholas D Riopel (ND)

Department of Medicine, University of Alberta, Edmonton, AB T6G 2G3, Canada.

Richard Long (R)

Department of Medicine, University of Alberta, Edmonton, AB T6G 2G3, Canada.
Tuberculosis Program Evaluation and Research Unit, University of Alberta, Edmonton, AB T6G 2J3, Canada.

Courtney Heffernan (C)

Department of Medicine, University of Alberta, Edmonton, AB T6G 2G3, Canada.
Tuberculosis Program Evaluation and Research Unit, University of Alberta, Edmonton, AB T6G 2J3, Canada.

Gregory J Tyrrell (GJ)

Division of Diagnostic and Applied Microbiology, Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB T6G 2J2, Canada.
Alberta Public Health Laboratory, Alberta Health Services, Edmonton, AB T6G 2B7, Canada.

Cary Shandro (C)

Alberta Public Health Laboratory, Alberta Health Services, Edmonton, AB T6G 2B7, Canada.

Vincent Li (V)

Alberta Public Health Laboratory, Alberta Health Services, Edmonton, AB T6G 2B7, Canada.

Md Rashedul Islam (MR)

National Reference Centre for Mycobacteriology, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba R3E 3P6, Canada.

Michael Stobart (M)

National Reference Centre for Mycobacteriology, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba R3E 3P6, Canada.

Meenu K Sharma (MK)

National Reference Centre for Mycobacteriology, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba R3E 3P6, Canada.
Department of Medical Microbiology and Infectious Diseases, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba R3E 0J9, Canada.

Hafid Soualhine (H)

National Reference Centre for Mycobacteriology, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba R3E 3P6, Canada.
Department of Medical Microbiology and Infectious Diseases, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba R3E 0J9, Canada.

Ryan Cooper (R)

Alberta Tuberculosis Control Program, Edmonton, AB T6G 2J3, Canada.
Division of Infectious Diseases, Department of Medicine, University of Alberta, Edmonton, AB T6G 2G3, Canada.

Classifications MeSH